Anzeige
Mehr »
Login
Montag, 20.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News! 22 Jahre "BlueChip"-Power nun bei NurExone!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Tradegate
20.05.24
16:31 Uhr
1,651 Euro
+0,057
+3,58 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,5501,62421:13
1,5251,64321:15

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrChina's Fosun Pharma to List Unit After It Bagged USD41.5 Million Investment6
DiFOSUN PHARMA (02196): ANNOUNCEMENT - PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ITS APPENDICES6
09.05.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY5
07.05.FAST NEWS: Fosun Pharma hits pause button on share buyback program8
29.04.FOSUN PHARMA (02196): 2024 FIRST QUARTERLY REPORT5
24.04.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY3
24.04.FOSUN PHARMA (02196): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS2
24.04.FOSUN PHARMA (02196): ANNUAL REPORT 20235
17.04.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION5
17.04.FOSUN PHARMA (02196): DATE OF BOARD MEETING5
08.04.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION5
26.03.FOSUN PHARMA (02196): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 20237
26.03.FOSUN PHARMA (02196): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20234
22.03.FOSUN PHARMA (02196): TERMS OF REFERENCE AND IMPLEMENTATION RULES OF THE REMUNERATION AND APPRAISAL COMMITTEE UNDER THE BOARD OF DIRECTORS4
22.03.FOSUN PHARMA (02196): TERMS OF REFERENCE AND IMPLEMENTATION RULES OF THE NOMINATION COMMITTEE UNDER THE BOARD OF DIRECTORS1
22.03.FOSUN PHARMA (02196): TERMS OF REFERENCE AND IMPLEMENTATION RULES OF THE AUDIT COMMITTEE UNDER THE BOARD OF DIRECTORS3
20.03.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE PASSING OF GMP COMPLIANCE INSPECTION OF A SUBSIDIARY6
14.03.Fosun Pharma joins Shenzhen government to raise US$700 million healthcare fund to invest in biomedicine innovation7
13.03.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY4
12.03.FOSUN PHARMA (02196): VOLUNTARY ANNOUNCEMENT - ENTERING INTO THE TARGET FUND PARTNERSHIP AGREEMENT4
Seite:  Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1